Page 2271 - Williams Hematology ( PDFDrive )

2246 Part XII: Hemostasis and Thrombosis Chapter 131: The Antiphospholipid Syndrome 2247

13. Feinstein DI, Rapaport SI: Acquired inhibitors of blood coagulation, in Progress in 44. Jankowski M, Vreys I, Wittevrongel C, et al: Thrombogenicity of beta 2-glycoprotein
Hemostasis and Thrombosis, edited by TH Spaet pp 75–95. Grune & Stratton, New York, I-dependent antiphospholipid antibodies in a photochemically induced thrombosis
1972. model in the hamster. Blood 101:157–162, 2003.
14. Beaumont JL: Acquired hemorrhagic syndrome caused by a circulating anticoagulant; 45. Arad A, Proulle V, Furie RA, et al: Beta(2)-Glycoprotein-1 autoantibodies from patients
inhibition of the thromboplastic function of the blood platelets; description of a specific with antiphospholipid syndrome are sufficient to potentiate arterial thrombus forma-
test. Sang 25:1–15, 1954. tion in a mouse model. Blood 117:3453–3459, 2011.
15. Nilsson IM, Astedt B, Hedner U, Berezin D: Intrauterine death and circulating antico- 46. Loizou S, Singh S, Wypkema E, Asherson RA: Anticardiolipin, anti-beta(2)-glycopro-
agulant (“antithromboplastin”). Acta Med Scand 197:153–159, 1975. tein I and antiprothrombin antibodies in black South African patients with infectious
16. Bowie EJ, Thompson JH Jr, Pascuzzi CA, Owen GA Jr: Thrombosis in systemic erythe- disease. Ann Rheum Dis 62:1106–1111, 2003.
matosus despite circulating anticoagulants. J Clin Invest 62:416–430, 1963. 47. Roubey RA, Pratt CW, Buyon JP, Winfield JB: Lupus anticoagulant activity of auto-
17. Harris EN, Gharavi AE, Boey ML, et al: Anticardiolipin antibodies: Detection by immune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. J Clin
radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Invest 90:1100–1104, 1992.
Lancet 2:1211–1214, 1983. 48. Galli M, Comfurius P, Maassen C, et al: Anticardiolipin antibodies (ACA) directed not
18. Miyakis S, Lockshin MD, Atsumi T, et al: International consensus statement on an to cardiolipin but to a plasma protein cofactor. Lancet 335:1544–1547, 1990.
update of the classification criteria for definite antiphospholipid syndrome (APS). 49. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Anti-phospholipid antibodies are
J Thromb Haemost 4:295–306, 2006. directed against a complex antigen that includes a lipid-binding inhibitor of coagula-
19. Lieby P, Soley A, Knapp AM, et al: Memory B cells producing somatically mutated tion: Beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120–4124,
antiphospholipid antibodies are present in healthy individuals. Blood 102:2459–2465, 1990.
2003. 50. Goldsmith GH, Pierangeli SS, Branch DW, et al: Inhibition of prothrombin activation
20. Giles I, Lambrianides A, Rahman A: Examining the non-linear relationship between by antiphospholipid antibodies and beta 2-glycoprotein 1. Br J Haematol 87:548–554,
monoclonal antiphospholipid antibody sequence, structure and function. Lupus 1994.
17:895–903, 2008. 51. de Laat HB, Derksen RH, Urbanus RT, de Groot PG: IgG antibodies that recognize
21. Cruz-Tapias P, Blank M, Anaya JM, Shoenfeld Y: Infections and vaccines in the etiology epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their pres-
of antiphospholipid syndrome. Curr Opin Rheumatol 24:389–393, 2012. ence correlates strongly with thrombosis. Blood 105:1540–1545, 2005.
22. Barcat D, Constans J, Seigneur M, et al: Deep venous thrombosis in an adult with vari- 52. de Laat B, Wu XX, van Lummel M, et al: Correlation between antiphospholipid anti-
cella. Rev Med Interne 19:509–511, 1998. bodies that recognize domain i of β -glycoprotein I and a reduction in the anticoagulant
2
23. Peyton BD, Cutler BS, Stewart FM: Spontaneous tibial artery thrombosis associated activity of annexin A5. Blood 109:1490–1494, 2007.
with varicella pneumonia and free protein S deficiency. J Vasc Surg 27:563–567, 1998. 53. Hunt BJ, Wu XX, de Laat B, et al: Association of anti-β GPI domain I IgG and resis-
2
24. Prieto J, Yuste JR, Beloqui O, et al: Anticardiolipin antibodies in chronic hepatitis C: tance to annexin A5 with obstetrical antiphospholipid syndrome: Evidence for a
Implication of hepatitis C virus as the cause of the antiphospholipid syndrome [see specific mechanism in a patient subset. ASH Annual Meeting Abstracts 112:3821,
comments]. Hepatology 23:199–204, 1996. 2008.
25. Cojocaru IM, Cojocaru M, Iacob SA: High prevalence of anticardiolipin antibodies in 54. Hunt BJ, Wu XX, de LB, et al: Resistance to annexin A5 anticoagulant activity in women
patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke. with histories for obstetric antiphospholipid syndrome. Am J Obstet Gynecol 205:485.
Rom J Intern Med 43:89–95, 2005. e17–485.e23, 2011.
26. Labarca JA, Rabaggliati RM, Radrigan FJ, et al: Antiphospholipid syndrome associated 55. Agar C, van Os GM, Mörgelin M, et al: Beta-2-glycoprotein I can exist in 2 confor-
with cytomegalovirus infection: Case report and review. Clin Infect Dis 24:197–200, mations: Implications for our understanding of the antiphospholipid syndrome. Blood
1997. 116:1336–1343, 2010.
27. Delbos V, Abgueguen P, Chennebault JM, et al: Acute cytomegalovirus infection and 56. Balasubramanian K, Maiti SN, Schroit AJ: Recruitment of beta-2-glycoprotein 1 to cell
venous thrombosis: Role of antiphospholipid antibodies. J Infect 54:e47–e50, 2007. surfaces in extrinsic and intrinsic apoptosis. Apoptosis 10:439–446, 2005.
28. Loizou S, Cazabon JK, Walport MJ, et al: Similarities of specificity and cofactor depen- 57. Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ: Beta-2-glycoprotein 1-depen-
dence in serum antiphospholipid antibodies from patients with human parvovirus B19 dent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related pro-
infection and from those with systemic lupus erythematosus. Arthritis Rheum 40:103– tein receptor family members. J Biol Chem 283:3761–3766, 2008.
108, 1997. 58. Matsuura E, Kobayashi K, Matsunami Y, Lopez LR: The immunology of atherothrom-
29. Martin E, Winn R, Nugent K: Catastrophic antiphospholipid syndrome in a commu- bosis in the antiphospholipid syndrome: Antigen presentation and lipid intracellular
nity-acquired methicillin-resistant Staphylococcus aureus infection: A review of patho- accumulation. Autoimmun Rev 8:500–505, 2009.
genesis with a case for molecular mimicry. Autoimmun Rev 10:181–188, 2011. 59. Agar C, de Groot PG, Morgelin M, et al: Beta2-glycoprotein I: A novel component of
30. Galrao L, Brites C, Atta ML, et al: Antiphospholipid antibodies in HIV-positive patients. innate immunity. Blood 117:6939–6947, 2011.
Clin Rheumatol 26:1825–1830, 2007. 60. Hulstein JJ, Lenting PJ, de Laat B, et al: Beta2-Glycoprotein I inhibits von Willebrand
31. Blank M, Aron-Maor A, Shoenfeld Y: From rheumatic fever to Libman-Sacks endocar- factor dependent platelet adhesion and aggregation. Blood 110:1483–1491, 2007.
ditis: Is there any possible pathogenetic link? Lupus 14:697–701, 2005. 61. Bu C, Gao L, Xie W, et al: Beta2-glycoprotein i is a cofactor for tissue plasminogen
32. Gotoh M, Matsuda J: Induction of anticardiolipin antibody and/or lupus anticoagu- activator-mediated plasminogen activation. Arthritis Rheum 60:559–568, 2009.
lant in rabbits by immunization with lipoteichoic acid, lipopolysaccharide and lipid A. 62. Ma K, Simantov R, Zhang JC, et al: High affinity binding of beta 2-glycoprotein I to
Lupus 5:593–597, 1996. human endothelial cells is mediated by annexin II. J Biol Chem 275:15541–15548, 2000.
33. Eschwege V, Freyssinet JM: The possible contribution of cell apoptosis and necrosis to 63. Sheng Y, Reddel SW, Herzog H, et al: Impaired thrombin generation in beta 2-glycopro-
the generation of phospholipid-binding antibodies. Ann Med Interne (Paris) 147(Suppl tein I null mice. J Biol Chem 276:13817–13821, 2001.
1):33–35, 1996. 64. Robertson SA, Roberts CT, van Beijering E, et al: Effect of beta2-glycoprotein I null
34. Price BE, Rauch J, Shia MA, et al: Anti-phospholipid autoantibodies bind to apoptotic, mutation on reproduction outcome and antiphospholipid antibody mediated preg-
but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J Immunol nancy pathology in mice. Mol Hum Reprod 10:409–416, 2004.
157:2201–2208, 1996. 65. de-Groot PG, Horbach DA, Derksen RH: Protein C and other cofactors involved in the
35. Pittoni V, Isenberg D: Apoptosis and antiphospholipid antibodies. Semin Arthritis binding of antiphospholipid antibodies: Relation to the pathogenesis of thrombosis.
Rheum 28:163–178, 1998. Lupus 5:488–493, 1996.
36. Inic-Kanada A, Stojanovic M, Zivkovic I, et al: Murine monoclonal antibody 26 raised 66. Atsumi T, Khamashta MA, Amengual O, et al: Binding of anticardiolipin antibodies to
against tetanus toxoid cross-reacts with beta2-glycoprotein I: Its characteristics and role protein C via beta2-glycoprotein I (beta2-GPI): A possible mechanism in the inhibi-
in molecular mimicry. Am J Reprod Immunol 61:39–51, 2009. tory effect of antiphospholipid antibodies on the protein C system. Clin Exp Immunol
37. Blank M, Asherson RA, Cervera R, Shoenfeld Y: Antiphospholipid syndrome infectious 112:325–333, 1998.
origin. J Clin Immunol 24:12–23, 2004. 67. Bidot CJ, Jy W, Horstman LL, et al: Factor VII/VIIa: A new antigen in the anti-phospho-
38. Gharavi AE, Pierangeli SS, Espinola RG, et al: Antiphospholipid antibodies induced in lipid antibody syndrome. Br J Haematol 120:618–626, 2003.
mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and 68. Ortona E, Capozzi A, Colasanti T, et al: Vimentin/cardiolipin complex as a new anti-
activation of endothelial cells in vivo. Arthritis Rheum 46:545–552, 2002. genic target of the antiphospholipid syndrome. Blood 116:2960–2967, 2010.
39. Hellan M, Kuhnel E, Speiser W, et al: Familial lupus anticoagulant: A case report and 69. Shibata S, Harpel PC, Gharavi A, et al: Autoantibodies to heparin from patients with
review of the literature. Blood Coagul Fibrinolysis 9:195–200, 1998. antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin
40. Weber M, Hayem G, DeBandt M, et al: The family history of patients with primary or complexes. Blood 83:2532–2540, 1994.
secondary antiphospholipid syndrome (APS). Lupus 9:258–263, 2000. 70. Lieby P, Soley A, Levallois H, et al: The clonal analysis of anticardiolipin antibodies in
41. Garcia CO, Kanbour-Shakir A, Tang H, et al: Induction of experimental antiphospho- a single patient with primary antiphospholipid syndrome reveals an extreme antibody
lipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J heterogeneity. Blood 97:3820–3828, 2001.
Reprod Immunol 37:118–124, 1997. 71. Andree HAM, Hermens WT, Hemker HC, Willems GM: Displacement of factor Va by
42. Holers VM, Girardi G, Mo L, et al: Complement C3 activation is required for antiphos- annexin V, in Phospholipid Binding and Anticoagulant Action of Annexin V, edited by
pholipid antibody-induced fetal loss. J Exp Med 195:211–220, 2002. HAM Andree, pp 73–85. Universitaire Pers Maastricht, Maastricht, The Netherlands,
43. Pierangeli SS, Liu X, Espinola R, et al: Functional analyses of patient-derived IgG 1992.
monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcir- 72. Reviakine I, Bergsma-Schutter W, Brisson A: Growth of protein 2-D crystals on sup-
culation models. Thromb Haemost 84:388–395, 2000. ported planar lipid bilayers imaged in situ by AFM. J Struct Biol 121:356–361, 1998.

Kaushansky_chapter 131_p2233-2252.indd 2246 9/18/15 5:10 PM